The purpose of this project is to explore how Black women experience and navigate the postpartum year after childbirth.

Do you have severe sickle cell disease? If so, you may be eligible to participate in a research study that is looking at the safety and effectiveness of using your own modified stem cells as possible treatment.

This study is creating and improving a program that will be used during inpatient treatment to help better teach skills in virtual school settings for adolescents hospitalized for suicide-related crises.

This research study is looking at a newer treatment option for Barrett's Esophagus (BE) which uses Nitrous Oxide to freeze unwanted tissue. The most commonly used treatment method is Radiofrequency Ablation (RFA) which uses heat to destroy the pre-cancerous tissue. Nitrous Oxide ablation using the C2 CryoBalloon Focal Ablation System, an FDA cleared device, is another, newer way of treating Barrett's Esophagus. To evaluate the newer treatment, we are enrolling patients who are not responding as well as expected to RFA. Patients with at least 2 or more previous RFA treatments who still have BE may be eligible.

In this study, we want to learn more about young adults with a history of concussion and their relationship with stress and mindfulness. This will help us to create concussion prevention and rehab plans to improve recovery.

Are you a trained male runner interested in how to get an edge on the competition? A group of researchers in the EXSS department is investigating the benefit of carbon fiber-plated running shoes on running economy (efficiency). All participants will receive personal VO2max, gait analysis and kinematic data upon completion of the study. Participants must have run an 18:00 5k (males) or 21:00 5K (females), or a comparable performance in another distance event in the past year.

Does your child have frequently relapsing or steroid dependent nephrotic syndrome? This study is testing a medicine called obinutuzumab, and comparing it with another one, mycophenolate mofetil (MMF), to see which works better for children with nephrotic syndrome.

Do you have Alpha-1 antitrypsin deficiency?

In this study, we want to measure how the muscles in your legs activate when putting different levels of force on your knee.

The purpose of this study is to test whether the Relivion® device is safe and helpful in reducing Major Depressive Disorder (MDD) symptoms. An earlier study showed positive results, and the company that developed the device, Neurolief, would like to get marketing clearance in the US and EU using the results of this research.